RDY is a debt-free, highly conservative company esp in the public company space. It has been one of the great companies listed in the indian exchange having given something like 1000% returns for the investor. it is obviously still a very small company. but the growth will be enormous in the coming years. with 2 or 3 specialty products(amlodipine being one) and a few generic exclusivities(zyprexa being one) it could well be sitting with a $1 billion cash. what i see happening at that stage is RDY buying some indian pharmas like lupin, glenmark or possily even ranbaxy(i know how much $1 billion can buy in india)
no they do not have ADR's. i think both are >$100-200 million in revenues. reddy's if successful in their NDA strategies for amvaz and allegra will pile a huge amount cash in 2-3 years(the last i checked they had $170 mill) I believe the allegra NDA was filed about 6-8 months back. and my research suggests that 2005 when they could get their product if everything goes dr.reddy's way. I am a long term holder in this stock. Even if this stock goes to RDY i wouldn't sell this. - gold
you stupid...you lost your mind...you have any idea how big reddy's will be when they get their first new drug. For starters, go find what were the sales numbers for prilosec for it's last 4 years of exclusivity(I will give it away...$26 billion with a B). Ranbaxy has been good in getting generics are a leap year back when it comes to discovery. Just with their NDA's alone, I easily see Reddy's in the next 5 years having the wherewithal to buy a company like ranbaxy.